A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

• Published in: Science (American Association for the Advancement of Science) Vol. 369; no. 6504; pp. 650 - 655
• Main Authors: Chi, Xiangyang, Yan, Renhong, Zhang, Jun, Zhang, Guanying, Zhang, Yuanyuan, Hao, Meng, Zhang, Zhe, Fan, Pengfei, Dong, Yunzhu, Yang, Yilong, Chen, Zhengshan, Guo, Yingying, Zhang, Jinlong, Li, Yaning, Song, Xiaohong, Chen, Yi, Xia, Lu, Fu, Ling, Hou, Lihua, Xu, Junjie, Yu, Changming, Li, Jianmin, Zhou, Qiang, Chen, Wei
• Format: Journal Article
• Language: English
• Published: United States The American Association for the Advancement of Science 07.08.2020; American Association for the Advancement of Science
• Subjects: Adult; Angiotensin-Converting Enzyme 2; Animals; Antibodies; Antibodies, Monoclonal - blood; Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal - immunology; Antibodies, Monoclonal - metabolism; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - chemistry; Antibodies, Neutralizing - immunology; Antibodies, Neutralizing - metabolism; Antibodies, Viral - blood; Antibodies, Viral - chemistry; Antibodies, Viral - immunology; Antibodies, Viral - metabolism; Antibody Affinity; Antibody Specificity; Antigens, Viral - immunology; B-Lymphocytes - immunology; Betacoronavirus - immunology; Binding; Biochem; Cell fusion; Chlorocebus aethiops; Coronaviridae; Coronavirus Infections - immunology; Coronavirus Infections - therapy; Coronavirus Nucleocapsid Proteins; Coronaviruses; COVID-19; Cryoelectron Microscopy; Electron microscopy; Enzyme-Linked Immunosorbent Assay; Epitopes; Genes, Immunoglobulin Heavy Chain; Humans; Immunologic Memory; Membrane fusion; Microbio; Microscopy; Middle Aged; Monoclonal antibodies; Mutation; Neutralization; Neutralizing; Nucleocapsid Proteins - immunology; Pandemics; Peptidyl-Dipeptidase A - metabolism; Phosphoproteins; Pneumonia, Viral - immunology; Pneumonia, Viral - therapy; Protein Domains; Protein Interaction Domains and Motifs - immunology; Proteins; Receptors; Receptors, Coronavirus; Receptors, Virus - metabolism; Respiratory diseases; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - chemistry; Spike Glycoprotein, Coronavirus - immunology; Spike Glycoprotein, Coronavirus - metabolism; Spike protein; Target spot; Vero Cells; Viral diseases; Viruses; Young Adult
• ISSN: 0036-8075; 1095-9203; 1095-9203
• DOI: 10.1126/science.abc6952

A key target for therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the spike protein, a trimeric protein complex with each monomer comprising an S1 and an S2 domain that mediate binding to host cells and membrane fusion, respectively. In addition to the receptor binding domain (RBD), S1 has an N-terminal domain (NTD). In searching for neutralizing antibodies, there has been a focus on the RBD. Chi et al. isolated antibodies from 10 convalescent patients and identified an antibody that potently neutralizes the virus but does not bind the RBD. Cryo–electron microscopy revealed the epitope as the NTD. This NTD-targeting antibody may be useful to combine with RBD-targeting antibodies in therapeutic cocktails. Science , this issue p. 650 A region outside of the receptor binding domain of SARS-CoV-2 is targeted by a neutralizing antibody. Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein but also across the full Spike (S) protein. We isolated and characterized monoclonal antibodies (mAbs) from 10 convalescent COVID-19 patients. Three mAbs showed neutralizing activities against authentic SARS-CoV-2. One mAb, named 4A8, exhibits high neutralization potency against both authentic and pseudotyped SARS-CoV-2 but does not bind the RBD. We defined the epitope of 4A8 as the N-terminal domain (NTD) of the S protein by determining with cryo–eletron microscopy its structure in complex with the S protein to an overall resolution of 3.1 angstroms and local resolution of 3.3 angstroms for the 4A8-NTD interface. This points to the NTD as a promising target for therapeutic mAbs against COVID-19.